Utilize este identificador para referenciar este registo: http://hdl.handle.net/10451/32815
Título: Antibody approaches to treat brain diseases
Autor: Neves, Vera
Silva, Frederico Aires da
Real, Sofia Corte
Castanho, Miguel A. R. B.
Data: 2016
Editora: Elsevier
Citação: Trends in Biotechnology, January 2016, Vol. 34, No. 1
Resumo: Recombinant antibodies are an emerging class of therapeutics with substantial promise to treat central nervous system (CNS) diseases such as Alzheimer's, Parkinson's, stroke, and brain cancers. However, poor blood–brain barrier (BBB) permeability hinders the progress of antibody therapies for conditions in which the target is located in the brain. Nonetheless, antibodies can nowa-days be engineered to enhance their therapeutic applications and translocation of the BBB using the natural portals of the brain. This paper reviews advances in the development and engineering of therapeutic BBB-crossing antibodies and their high potential for treatment of CNS disorders.
Descrição: © 2015 Elsevier Ltd.
Peer review: yes
URI: http://hdl.handle.net/10451/32815
DOI: 10.1016/j.tibtech.2015.10.005
ISSN: 0167-7799
Versão do Editor: https://www.journals.elsevier.com/trends-in-biotechnology
Aparece nas colecções:IMM - Artigos em Revistas Internacionais

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Antibody_brain.pdf2,18 MBAdobe PDFVer/Abrir    Acesso Restrito. Solicitar cópia ao autor!
32815_FREE_Post-Print.pdf1,67 MBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.